Suzanne Turner
Family Medicine · Roswell, GANPI 1023045663
Payments from drug & device makers
Across 422 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$935
- Lilly USA, LLC$777
- Abbott$667
- Pfizer$408
- AstraZeneca$222
- plus $2K from 25 others
What the payments were for
- Food & beverage$6,899100%
- Education$320%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 104 | $2,027 |
| Novo Nordisk | 79 | $935 |
| Lilly USA, LLC | 43 | $777 |
| Abbott | 59 | $667 |
| Pfizer | 22 | $408 |
| AstraZeneca | 14 | $222 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $211 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $198 |
| IBSA Pharma Inc. | 9 | $176 |
| Amgen | 8 | $146 |
| Arbor Pharmaceuticals, Inc. | 7 | $132 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $109 |
| GSK | 5 | $101 |
| Eisai Inc. | 7 | $99 |
| Merck | 5 | $81 |
| Romark Laboratories, LC | 6 | $81 |
| Novartis | 4 | $78 |
| Kvk-tech, Inc. | 2 | $75 |
| Astellas Pharma US Inc | 4 | $75 |
| Biohaven Pharmaceuticals, Inc. | 2 | $61 |
| Daiichi Sankyo Inc. | 3 | $60 |
| Exact Sciences | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Linus Health, Inc. | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Concordia Pharmaceuticals Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$124
How this compares
$6,932 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 42 | $42,937 |
| XareltoRivaroxaban | 12 | $12,714 |
| BelsomraSuvorexant | 12 | $5,255 |
| Liothyronine Sodium | 34 | $1,626 |
| Estradiol (Twice Weekly)Estradiol | 19 | $1,359 |
| SynthroidLevothyroxine Sodium | 13 | $700 |
| ProgesteroneProgesterone, Micronized | 23 | $662 |
| Testosterone Cypionate | 17 | $619 |
| Pregabalin | 13 | $503 |
| Trazodone Hcl | 13 | $315 |
| Levothyroxine Sodium | 33 | $297 |
| Atorvastatin Calcium | 16 | $132 |
| Zolpidem Tartrate | 13 | $40 |
| Azithromycin | 15 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $935 | $42,93742 claims |
| MerckBelsomra | $81 | $5,25512 claims |
| AbbVieSynthroid | $2,027 | $70013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Roswell
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.